Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients
Acta Gastro Enterologica Belgica · 2024-10 · 87 (3) · 388-392
DOI: 10.51821/87.3.13290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Gastro Enterologica Belgica, 2024-10. Verfasst von K H Dilcan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Liver Cirrhosis, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background & Aims: Chronic hepatitis B is still a major cause of morbidity and mortality worldwide. In recent years, there has been increasing research on inexpensive, noninvasive, reproducible methods for detecting fibrosis in the liver. In this study, we examined the efficacy of 15 different noninvasive fibrosis markers for predicting significant liver fibrosis in chronic hepatitis B patients.
Methods
Patients who underwent liver biopsy for chronic hepatitis B between 01.01.2010 and 01.01.2022 were retrospectively analysed. The study population was divided into two groups according to significant fibrosis (F≥3). Receiver operating characteristic analysis was performed to examine the diagnostic performance of these noninvasive fibrosis markers for the prediction of significant fibrosis. Multiple logistic regression analysis was used create a model which predicts significant fibrosis better than the individual markers.
Results
In total, 234 chronic hepatitis B patients were enrolled in this study. Among the 15 noninvasive fibrosis markers, King’s score was found to have the biggest AUC in predicting significant fibrosis (F≥3). Furthermore, a model containing King’s score, GUCI and GPR has the ability of prediction of significant fibrosis better than every individual marker (cut-off of the model >0,3356, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Clinical Microbiology, Abant Izzet Baysal University Faculty of Medicine, Bolu, Turkey.
Zitieren
APA
Dilcan, K. H., & Gozdas, H. T. (2024). Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients. Acta Gastro Enterologica Belgica, 87(3), 388-392. https://doi.org/10.51821/87.3.13290
Vancouver
Dilcan KH, Gozdas HT. Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients. Acta Gastro Enterologica Belgica. 2024;87(3):388-392. doi:10.51821/87.3.13290
BibTeX
@article{Dilcan2024,
author = {Dilcan, K H and Gozdas, H T},
title = {Noninvasive evaluation of significant liver fibrosis in chronic hepatitis B patients},
journal = {Acta Gastro Enterologica Belgica},
year = {2024},
volume = {87},
number = {3},
pages = {388--392},
doi = {10.51821/87.3.13290}
}
EUVIMED